Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nacho Aguilo

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal for Immunotherapy of Cancer|April 4, 2020
Cell death induced by cytotoxic CD8<sup>+</sup> T cells is immunogenic and primes caspase-3-dependent spread immunity against endogenous tumor antigensPaula Jaime-Sanchez, Iratxe Uranga-Murillo, Nacho Aguilo, et al.
Vaccine|July 29, 2014
Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in miceLuis Solans, Santiago Uranga, Nacho Aguilo, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 28, 2018
Therapeutic efficacy of the live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in a preclinical model of bladder cancerSamuel Alvarez-Arguedas, Santiago Uranga, Manuel Martín, et al.
Clinical and Vaccine Immunology : CVI|February 7, 2014
Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccinationNacho Aguilo, Ana Maria Toledo, Eva Maria Lopez-Roman, et al.
Molecular Therapy. Methods & Clinical Development|March 13, 2019
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against <i>Mycobacterium tuberculosis</i> in MiceEsther Broset, Narcís Saubi, Núria Guitart, et al.
Nature Communications|July 15, 2017
Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosisNacho Aguilo, Jesus Gonzalo-Asensio, Samuel Alvarez-Arguedas, et al.
Plos Pathogens|December 21, 2020
Independent genomic polymorphisms in the PknH serine threonine kinase locus during evolution of the Mycobacterium tuberculosis Complex affect virulence and host preferenceElena Mata, Damien Farrell, Ruoyao Ma, et al.
Ebiomedicine|March 12, 2021
BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studiesEsther Broset, Jacobo Pardo-Seco, Alex I Kanno, et al.
Plos Pathogens|April 3, 2020
New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumoniaRaquel Tarancón, Jorge Domínguez-Andrés, Santiago Uranga, et al.
Journal for Immunotherapy of Cancer|July 5, 2022
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsEduardo Moreo, Santiago Uranga, Ana Picó, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|April 4, 2020
Cell death induced by cytotoxic CD8<sup>+</sup> T cells is immunogenic and primes caspase-3-dependent spread immunity against endogenous tumor antigensPaula Jaime-Sanchez, Iratxe Uranga-Murillo, Nacho Aguilo, et al.
Vaccine|July 29, 2014
Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in miceLuis Solans, Santiago Uranga, Nacho Aguilo, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 28, 2018
Therapeutic efficacy of the live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in a preclinical model of bladder cancerSamuel Alvarez-Arguedas, Santiago Uranga, Manuel Martín, et al.
Clinical and Vaccine Immunology : CVI|February 7, 2014
Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccinationNacho Aguilo, Ana Maria Toledo, Eva Maria Lopez-Roman, et al.
Molecular Therapy. Methods & Clinical Development|March 13, 2019
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against <i>Mycobacterium tuberculosis</i> in MiceEsther Broset, Narcís Saubi, Núria Guitart, et al.
Nature Communications|July 15, 2017
Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosisNacho Aguilo, Jesus Gonzalo-Asensio, Samuel Alvarez-Arguedas, et al.
Plos Pathogens|December 21, 2020
Independent genomic polymorphisms in the PknH serine threonine kinase locus during evolution of the Mycobacterium tuberculosis Complex affect virulence and host preferenceElena Mata, Damien Farrell, Ruoyao Ma, et al.
Ebiomedicine|March 12, 2021
BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studiesEsther Broset, Jacobo Pardo-Seco, Alex I Kanno, et al.
Plos Pathogens|April 3, 2020
New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumoniaRaquel Tarancón, Jorge Domínguez-Andrés, Santiago Uranga, et al.
Journal for Immunotherapy of Cancer|July 5, 2022
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsEduardo Moreo, Santiago Uranga, Ana Picó, et al.
Pageof 4